These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7338190)

  • 1. Use of cefamandole in the treatment of soft tissue and skeletal infections.
    LeFrock JL; Paparone P; Kowalsky SF; Schell RF; Jacobs RL; Wirth CR; Tillotson JR
    Drug Intell Clin Pharm; 1981 Dec; 15(12):951-7. PubMed ID: 7338190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology, Safety, and efficacy of cefamandole in childhood infections.
    Thirumoorthi MC; Dajani AS; Vincent CV; Maurer MJ
    Antimicrob Agents Chemother; 1981 Jul; 20(1):21-4. PubMed ID: 7283413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of osteomyelitis and septic arthritis with cefamandole.
    Bernstein BM; Fass RJ
    Am J Med Sci; 1982; 284(3):2-8. PubMed ID: 7148886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with cefamandole for treatment of serious bone and joint infections.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S119-S124. PubMed ID: 649996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefamandole in the treatment of serious bone and joint diseases.
    Levine LR
    Scand J Infect Dis Suppl; 1980; suppl 25():89-93. PubMed ID: 7010542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory evaluation of cefamandole in infants and children.
    Rodriguez WJ; Ross S; Khan WN; Goldenberg R
    J Infect Dis; 1978 May; 137 Suppl():S150-S154. PubMed ID: 306402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of cefamandole nafate.
    Rosett W; Hodges GR; Harms J; Gerjarusak P; Dworzack D; Hinthorn DR; Liu C
    Am J Med Sci; 1977; 274(2):153-61. PubMed ID: 341707
    [No Abstract]   [Full Text] [Related]  

  • 8. Cefamandole in the treatment of soft tissue infections.
    Ramírez-Ronda CH; Quiñones-Soto R; Lugo-Velázquez A; Bermúdez RH
    Chemotherapy; 1982; 28(3):224-8. PubMed ID: 7094663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of cefamandole in childhood infections.
    Paul RS; Kumar A; Worthington DC; Walton RO
    Clin Ther; 1983; 5(6):617-23. PubMed ID: 6627287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
    Perkins RL; Fass RJ; Warner JF; Prior RB; File TM; Tight RR; Gardner WG; Ruiz DE; Slama TG
    J Infect Dis; 1978 May; 137 Suppl():S110-S118. PubMed ID: 418126
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of long half-life parenteral cephalosporins in ambulatory practice.
    Sauerwein M; Deamer RL; Prichard JG
    J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetic studies on the availability of cephamandole in bone and joint infections].
    Wittmann DH; Schassan HH; Freitag F
    Ther Ggw; 1980 Dec; 119(12):1422-35. PubMed ID: 7466689
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and laboratory investigation of cefamandole therapy of infections in infants and children.
    Azimi PH
    J Infect Dis; 1978 May; 137 Suppl():S155-S160. PubMed ID: 349094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of serious skin and soft tissue infections with cefamandole.
    Glanges E; Webber CE; Crenshaw CA; Pasquet M; Barksdale L
    Scand J Infect Dis Suppl; 1980; suppl 25():69-74. PubMed ID: 7010539
    [No Abstract]   [Full Text] [Related]  

  • 15. Cefamandole nafate: an evaluation of antibacterial activity, serum levels, clinical effect, and incidence of side reactions in 58 patients.
    Ekwall E; Holmgren EB; Lundbergh P; Svanbom M; Tunevall G
    Scand J Infect Dis; 1979; 11(2):135-9. PubMed ID: 462128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of skin, skin structure, bone, and joint infections with ceftazidime.
    Gentry LO
    Am J Med; 1985 Aug; 79(2A):67-74. PubMed ID: 3895921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of serious infections with cefamandole.
    Parry MF; Goldberger MJ; Neu HC
    Infection; 1978; 6(5):236-40. PubMed ID: 365776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory investigation of cefamandole in infections of infants and children.
    Azimi PA
    Antimicrob Agents Chemother; 1978 Jun; 13(6):955-7. PubMed ID: 307939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)].
    Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefamandole therapy in anaerobic infections.
    Greenberg RN; Scalcini MC; Sanders CV; Lewis AC
    Antimicrob Agents Chemother; 1979 Mar; 15(3):337-41. PubMed ID: 380458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.